Discontinuation report ZOSTAVAX II
Report ID | 159386 |
Drug Identification Number | 02375516 |
Brand name | ZOSTAVAX II |
Common or Proper name | (zoster vaccine live, attenuated [Oka/Merck], refrigerator-stable) powder for suspension for injection |
Company Name | MERCK CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED |
Strength(s) | 19400PFU |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 1 dose vial |
ATC code | J07BK |
ATC description | VIRAL VACCINES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2022-10-14 |
Actual discontinuation date | 2022-10-14 |
Remaining supply date | 2022-10-14 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-04-26 | English | Compare |
v2 | 2022-04-26 | French | Compare |
v3 | 2022-10-12 | English | Compare |
v4 | 2022-10-14 | English | Compare |
v5 | 2022-10-14 | French | Compare |
v6 | 2022-10-15 | French | Compare |
Showing 1 to 6 of 6